Track Your Manuscript:
Enter Correct Manuscript Reference Number:

Coronaviruses

The World's First International Journal Dedicated to Coronaviruses

Volume 3, 12 Issues, 2022
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access

Subscribe to this Journal

Book Proposal

Become an Executive Guest Editor

New Journal Proposal

Become a Section Editor

Become a Reviewer

Join Editorial Board

Thematic Issue Proposal

Submit Abstract Online

Aims & Scope

Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.

The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.

Coronaviruses

Volume 3

Number 2

Biography

Meet the Editorial Board Member

, 3(2): e040322201689

David Jay Weber

DOI: 10.2174/266679670302220304094805

View Biography

Editorial

Onco-immunological Aspect of COVID-19: Current Progress and Perceptions

, 3(2): e280122200095

Suman Kumar Ray and Sukhes Mukherjee*

DOI: 10.2174/2666796703666220107122907

View Editorial Permissions

Perspective Article

COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures

, 3(2): e280122197574

Abhigyan Choudhury and Suprabhat Mukherjee*

DOI: 10.2174/2666796702666211102111805

View Abstract Permissions

Review Article (Mini-Review)

Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials

, 3(2): e030821188723

Md. Asaduzzaman Khan*, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania and Asaduzzaman Asad

DOI: 10.2174/2666796701999201204122819

View Abstract Permissions

Review Article

Impact on Pharmaceutical Industry due to Sudden Pandemic Attack (COVID-19)

, 3(2): e280122198187

Sudhanshu Mishra, Disha Sharma, Shobhit Prakash Srivastava, Swati Verma and Rishabha Malviya*

DOI: 10.2174/2666796702666211122152928

View Abstract Permissions

Review Article

A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2

, 3(2): e220122190597

Mona Sadat Larijani, Amitis Ramezani, Mohammad Reza Aghasadeghi and Seyed Mehdi Sadat*

DOI: 10.2174/2666796702666210122123559

View Abstract Permissions

Review Article

Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review

, 3(2): e041220188720

Pratyay Kumar Pahari, Sonal Vyas, Shahbaz Aman, Uday Singh, Kusheswar Prasad Singh, Rohit Tiwari and Meenakshi Dhanawat*

DOI: 10.2174/2666796701999201204115545

View Abstract Permissions

Review Article

Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration

, 3(2): e020221191025

Youness Kadil * and Houda Filali

DOI: 10.2174/2666796702666210202124417

View Abstract Permissions

Coronaviruses, Volume 3 (2022) - Number 3

This issue is in progress but contains articles that are final and fully citable.

Articles Ahead of Print

There are currently no Articles Ahead of Print available for this journal.

Abstracts Ahead of Print

COVID-19 Stress on Mental and Hair Health: A Marker for Diseases in the Post-Pandemic Era?

Daniela Xavier Accorsi, Ingrid Aparecida Mendes dos Santos, Juliana Xavier Accorsi, UrsulandrÃ©a Sanches Abelan, Celso Martin JÃºnior, Silvia Bohac, ValÃ©ria Bumiller-Bini, Angelica Beate Winter Boldt and Chung Man Chin*

DOI: 10.2174/2666796703666220408120226

View Abstract

Traditional therapies involving nutrition for the management of COVID-19

Ramesh M*, Arunachalam Muthuraman and Krishnan Anand

DOI: 10.2174/2666796703666220328143113

View Abstract

Functional role of natural antioxidants for controlling oxidative stress associated with SARS-Cov-2 infection

Subramani Parasuraman*, Venkata Kanthi Vaishnavi Vedam and Chakradhara Rao S Uppugunduri

DOI: 10.2174/2666796703666220324151004

View Abstract

Recent advances in understanding SARS-CoV-2 infection and updates on potential diagnostic and therapeutics for COVID-19

Damini Verma, Amit K. Yadav, Navneet Chaudhary, Maumita Das Mukherjee, Pramod Kumar, Anil Kumar and Pratima R Solanki*

DOI: 10.2174/2666796703666220302143102

View Abstract

Targeting Angiotensin-Converting Enzyme 2 (ACE2) for the Discovery of Anticoronaviral Drugs

N.S. Hari Narayana Moorthy*, Karthikeyan C. and Elangovan Manivannan

DOI: 10.2174/2666796703666220218100133

View Abstract

The Concept Of Repurposing In Covid-19 Infection

Lata Potey, Anshu Chaudhary Dudhe, Dhanashri Tumme, Rupesh Dudhea* and Prafulla Sable

DOI: 10.2174/2666796703666220204102622

View Abstract

Published Contents

Editor's Choice

Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges

, 2021; 2(12): 9 - 23

Coronaviruses

Aims & Scope

Coronaviruses

Volume 3

Number 2

Biography

Meet the Editorial Board Member

David Jay Weber

Editorial

Onco-immunological Aspect of COVID-19: Current Progress and Perceptions

Suman Kumar Ray and Sukhes Mukherjee*

Perspective Article

COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures

Abhigyan Choudhury and Suprabhat Mukherjee*

Review Article (Mini-Review)

Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials

Md. Asaduzzaman Khan*, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania and Asaduzzaman Asad

Review Article

Impact on Pharmaceutical Industry due to Sudden Pandemic Attack (COVID-19)

Sudhanshu Mishra, Disha Sharma, Shobhit Prakash Srivastava, Swati Verma and Rishabha Malviya*

Review Article

A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2

Mona Sadat Larijani, Amitis Ramezani, Mohammad Reza Aghasadeghi and Seyed Mehdi Sadat*

Review Article

Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review

Pratyay Kumar Pahari, Sonal Vyas, Shahbaz Aman, Uday Singh, Kusheswar Prasad Singh, Rohit Tiwari and Meenakshi Dhanawat*

Review Article

Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration

Youness Kadil * and Houda Filali

Coronaviruses, Volume 3 (2022) - Number 3

Review Article

Is There a Rendezvous for SARS-CoV-2 and Agmatine?

Nandkishor Kotagale, Brijesh Taksande and Nazma Inamdar

Review Article

COVID-19 Pandemic: An Overview of its Origin, Current Status, and Ongoing Clinical Trials

Kartik Majila, Seema Lal and Mohammad Faiz Ahmad*

Research Article

Assessment of Stress, Anxiety, and Depression Levels Among COVID-19 Positive Patients Admitted in Rural Tertiary Care Hospital

Ramakant Yadav, Neha Dubey, Shweta Jain, Ankur Vaidya* and Raj Kumar

Research Article

Chemi-Informatic Approach to Investigate Putative Pharmacoactive Agents of Plant Origin to Eradicate COVID-19

Amit Joshi, Vandna Sharma, Joginder Singh and Vikas Kaushik*

Editorial

Long Term Neurological Effects After Acute SARS-CoV-2 Infection

Mohammad Asif*

Research Article

Green Tea Catechins Against COVID-19: Lower COVID-19 Morbidity and Mortality in Countries with Higher per capita Green Tea Consumption

Maksim Storozhuk*

Articles Ahead of Print

Abstracts Ahead of Print

COVID-19 Stress on Mental and Hair Health: A Marker for Diseases in the Post-Pandemic Era?

Daniela Xavier Accorsi, Ingrid Aparecida Mendes dos Santos, Juliana Xavier Accorsi, UrsulandrÃ©a Sanches Abelan, Celso Martin JÃºnior, Silvia Bohac, ValÃ©ria Bumiller-Bini, Angelica Beate Winter Boldt and Chung Man Chin*

Traditional therapies involving nutrition for the management of COVID-19

Ramesh M*, Arunachalam Muthuraman and Krishnan Anand

Functional role of natural antioxidants for controlling oxidative stress associated with SARS-Cov-2 infection

Subramani Parasuraman*, Venkata Kanthi Vaishnavi Vedam and Chakradhara Rao S Uppugunduri

Recent advances in understanding SARS-CoV-2 infection and updates on potential diagnostic and therapeutics for COVID-19

Damini Verma, Amit K. Yadav, Navneet Chaudhary, Maumita Das Mukherjee, Pramod Kumar, Anil Kumar and Pratima R Solanki*

Targeting Angiotensin-Converting Enzyme 2 (ACE2) for the Discovery of Anticoronaviral Drugs

N.S. Hari Narayana Moorthy*, Karthikeyan C. and Elangovan Manivannan

The Concept Of Repurposing In Covid-19 Infection

Lata Potey, Anshu Chaudhary Dudhe, Dhanashri Tumme, Rupesh Dudhea* and Prafulla Sable

Published Contents

Editor's Choice

Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges

Habibur Rahman*

Lipid Lowering Natural Products Targeting hPCSK9 May Prevent the Severity of COVID-19 Infection

Ajoy Basak*, Jaishree Vaijanathappa and Sarmistha Basak

Review on Diagnostic Methods for SARS-CoV-2

Chandrashekhar Chauriya, Mahesh Sahu, Anuj Kumar Singh and Amita Verma*

Immunological Response of the Respiratory Tract in the SARS-CoV-2 Infection

Sanjiv Singh*, Punita Aggarwal and Velayutham Ravichandiran

In-silico Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors against Main Protease of SARSCoV- 2

Ravi S Patel, Akash G Vanzara, Nimisha R Patel, Ajit M Vasava, Sachin M Patil and Kishore S Rajput*

The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19

Carolina Restini*, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim and Courtney Merlo

The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review

Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, Md Sarfraz, Nawshad Muhammad and Syed A.A. Rizvi*

Emergence of a New Zoonotic COVID-19 that Creates a Pandemic: Update on Current Pharmacotherapeutics and Future Prospective of Plasma Therapy

Farazul Hoda, Rishabh Verma, Saurabh Rastogi, Asif Iqubal, Syed Ehtaishamul Haque, Mohd. Akhtar and Abul Kalam Najmi*

Onome Ejeromedoghene, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo and Richard O. Akinyeye

Karan Singh, Amit Kumar Mittal and Akash Gujral